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Abstract 
Emotional distress is a common symptom experienced by most cancer patients which is difficult to detect and if 
detected, only a small percentage receives treatment. It becomes worse over the course of treatment and after the 
end of therapy which negatively impact on the quality of life of the patients. This study looked at the prevalence 
of emotional distress of cancer patients undergoing chemotherapy and the factors that affects emotional distress. 
A cross-sectional study was done with 150 participants receiving chemotherapy at the National Centre for 
Radiotherapy, Korle-Bu. Data were collected using structured self-rated questionnaires. Emotional distress was 
assessed using the Hospital anxiety and depression scale (HADS) and linked with their clinical characteristics 
from their medical records. Chi-square was used to examine the factors that affect emotional distress. Out of 150 
participants, 89(59.3%) were distressed. More females were more distressed than men. Analysis indicated that 
the younger the age, low income level,   being employed and low educational status affects distress level. 
Common side effects of chemotherapy experienced by the patients were also related to high levels of distress. 
Emotional distress is relatively high in cancer patients receiving chemotherapy and it is affected by younger age, 
low income level, being employed and low educational status. Early detection and intervention of distress during 
chemotherapy will be easier if health professionals especially the oncology nurse screen patients before and 
during chemotherapy so as to know those who are vulnerable and need psychological care. 
Keywords: cancer, emotional distress, chemotherapy, hospital anxiety and depression scale, tumours 
1.0 INTRODUCTION 
Distress has been defined as multifactorial unpleasant emotional experience of a psychological (cognitive, 
behavioural, emotional), social and/or spiritual nature that interferes with the ability to cope with cancer and its 
treatments. It extends along a continuum, from common normal feelings of vulnerability, sadness, and fears, to 
problems that are disabling, such as true depression, anxiety, panic, and feeling isolated or in a spiritual crisis 
(NCCN, 2009). Emotional distress, the sixth vital sign is usually a normal reaction from diagnosis of cancer and 
/or its treatments. It could start from a feeling of sadness, fear and could be disabling to anxiety and depression 
(Zainel, et al 2007). Globally, cancer incidence is increasing, and is a major cause of morbidity and mortality. 
Much of the burden of cancer incidence, morbidity, and mortality will occur in the developing world and cancer 
is a leading cause of death worldwide and a public health problem. The disease accounted for 7.4 million deaths 
(or around 13% of all deaths worldwide) in 2004. More than 70% of all cancer deaths occurred in low- and 
middle-income countries (WHO, 2009).  
 
In Africa the cancer situation is worsening in several countries and many patients remain unscreened, 
undiagnosed and inadequately treated. According to the World Cancer Report 2008, new cancer cases are 
expected to rise from 13 million to nearly 27 million annually by 2030. By then, cancer will be killing some 17 
million people every year. In the African Region, there were an estimated 667,000 new cases of cancer in 2008 
affecting 314,000 males and 353,000 females and causing 518,000 deaths involving 252,000 males and 266,000 
females. WHO estimates that without appropriate intervention, 84 million people will die of cancer between 
2005 and 2015. In men, the commonest cancer, and the primary cause of cancer-related deaths, is Kaposi 
Sarcoma, followed by liver and prostate cancers. In women, cervical and breast cancers are the most common 
forms of cancer and related deaths. Accurate figures are not available as many cancer cases and deaths go 
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unreported. The cancer burden is not just a burden of pain, suffering and grief. It undermines society’s prospects 
for growth, prosperity and hope (Sambo, 2010). 
 
Anecdoctically, data from the cancer registry the Korle-Bu teaching hospital indicates that cancer incidence is on 
the increase. With a population of more than 20 million, Ghana expects up to 20,000 new cases of cancer therapy 
each year (Program of Action for Cancer Therapy, PACT- 2006). Most people with the disease, see cancer 
diagnosis as devastating, making the discovery more stressful than any other disease process (Sawyer, 2000). 
Therefore, there is a possibility of an increase in the number of cancer patients suffering from emotional distress. 
Holland (2002) noted that no disease has sustained as strong negative stigma as cancer and that cancer diagnosis 
leads to a complex set of issues including dealing with physical symptoms from disease and treatments. 
Developments in surgery, chemotherapy and radiotherapy mean that the survival rate of people diagnosed with 
cancer has increased (Bottomley, 1997; Paraska, & Bender, 2003).  Irrespective of the evolution in the 
treatments, emotional impact is high. Psychosocial issue affect patients in all stages of cancer and that the 
increase of cancer incidence means that psychological morbidity will also increase (Holland, 2002).  
 
Current literature suggests that much has been achieved in determining psychological distress in cancer patients 
(Grassi et al, 2004; Jacobsen et al, 2005; Gil et al, 2005). The prevalence of long-term psychological distress in 
cancer patients ranges from 20 to 66 % (Brietbat, 2005; Ricker et al, 1989). Anxiety is common at crisis points 
such as the start of a new treatment or the diagnosis of recurrence or illness progression (Noyes et al, 1998). 
Investigators have found that 44% of patients with cancer reported some anxiety and 23% reported significant 
anxiety (Stark et al, 2002 and Schag et al, 1989). Depression has been given much attention in cancer patients as 
its symptoms can be a normal reaction, a psychiatric disorder or a somatic consequence of cancer or its 
treatment. The rate of depression in cancer patients is higher than in the general population and at least as high as 
the rate associated with other serious medical illnesses (Massie, 2004). More than half of all people diagnosed 
with cancer receive chemotherapy. For millions of people, chemotherapy helps treat their cancer effectively, 
enabling them to enjoy full, productive lives (Ignoffo and Rosenbaum, 2008).   
 
Chemotherapy is a general term for treatments that use chemical agents (drugs) to kill cancer cells. In most solid 
tumours chemotherapy is used either as adjuvant (giving chemotherapy after a local treatment be it radiotherapy 
or surgery aiming at cure), neoadjuvant (giving chemotherapy to before surgery or radiotherapy aiming at 
controlling the cancer) and palliative chemotherapy is given without curative intent, but simply to decrease 
tumour load and increase life expectancy. In all the three ways the patients’ experiences side effects be it mild or 
severe.  Pandey et al (2006) emphasized that chemotherapy is an intense and cyclic treatment and unlike surgery 
has many side-effects like hair loss, nausea, vomiting, and diarrhoea. Long periods of treatment, repeated 
hospitalizations and side-effects of chemotherapy beside the knowledge of having cancer can all affect the 
psyche of these patients. Chemotherapy is considered a systemic treatment and due to this it results in a lot of 
side effects which may be temporary and uncomfortable including nausea and vomiting, alopecia, diarrhoea, 
anorexia, stomatitis fatigue, immunosuppression and others which usually may resolve once treatment is 
complete. These side effect irrespective they can be controlled brings about a lot of psychological effects such as 
anxiety and depression. Research in this area in Africa for that matter sub-Saharan Africa is limited thus a need 
for this study to contribute knowledge on the psychological effects on cancer patients for the treatment of cancer. 
The objective is to assess emotional distress in cancer patients undergoing chemotherapy and to identify factors 
that affect the level of distress in chemotherapy patients.  
 
2. MATERIALS AND METHODS 
2.1 Study Area and Design 
The study was carried out in the National Centre for Radiotherapy and Nuclear Medicine of Korle-Bu Teaching 
Hospital Accra, Ghana. Korle-Bu Teaching Hospital is the largest tertiary health care facility in Ghana situated 
in the Ablekuma South sub-metro district of the Greater Accra Region. The National Centre for Radiotherapy 
and Nuclear Medicine was established on 26th of May, 1998. It came into being through a collaborative effort 
between the Government of Ghana (acting through the Ministry of Health) and the International Atomic Energy 
Agency (acting through the Ghana Atomic Energy Commission). The centre mainly receives cancer patients 
from all over the country and from neighbouring countries. The main treatments offered are radiotherapy and 
chemotherapy mostly to solid tumours. Chemotherapy is mainly on outpatient basis. This setting was chosen 
because of accessibility, and the assumption that since this centre is the first radiotherapy centre, it would have 
more patients visiting it under a well organised health team.  
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2.2 Data collection technique and Tools 
Data were collected using structured questionnaires. Emotional distress was assessed using the Hospital Anxiety 
and Depression Scale (HADS). This scale is selected over others because it is widely used, easy for patients to 
answer and had being used in both cancer and non-cancer patients. The HADS is a self-rated 14-item 
questionnaire specifically designed for patients with medical illness. It has depression and anxiety subscales with 
seven items each. These two subscales correlate highly and HADS scores are frequently analysed as a single 
scale (Bjelland et al, 2002). Individual items are rated on a four-point scale (0–3), resulting in maximum scores 
of 21 on each subscale and a total maximum score of 42. The English version of the tool was used (Zigmond and 
Snaith, 1983). Clinically significant emotional distress is defined as a total HADS score of 15 or above. This cut 
off score was reported by Ibbotson et al (1994) to be the best for identifying patients likely to have an interview 
based diagnosis of depressive or anxiety disorder. The reliability, validity and factor structure of the HADS has 
been established in a variety of clinical populations (Mooreyet al, 1991; Johnston et al, 2000; Mykletun et al, 
2001; Smith et al, 2002). The data collection was done by interview with a structured questionnaire having 
demographic, clinical characteristics and the HADS. Also a separate sheet with a list of common side effects was 
given to patients to assess their side effects they were experiencing. 
The study was carried out from July to December 2011. 
 
2.3 Study Population and Sampling Method 
The study population involved patients that had been diagnosed with cancer and were receiving chemotherapy at 
the oncology department. Inclusion criteria: participants were included if they meet the following pre-defined 
criteria: between the ages of 18 – 80 years old (due to the fact that chemotherapy is not usually offered or 
advantageous to patients over the age of 80, and younger patients requiring chemotherapy are generally 
transferred to paediatric oncology unit for their treatment); able to speak and write the English language or have 
access to an interpreter (which will be researcher or assistants); have solid tumours; mentally competent. The 
exclusion criteria were those who were critically ill and found it difficult to communicate.  
 
Data were collected on One Hundred and Fifty (150) patients using structured questionnaires. They were 
purposively selected from the patients who were undergoing chemotherapy from the National Centre for 
Radiotherapy. Data from the unit indicated that within a week between 30 to 40 patients received chemotherapy.  
2.6 Pre –testing and Data Handling 
Two (2) field assistants, recruited for the data collection exercise, underwent a 3-day training program on data 
collection and handling. Since the interview was largely conducted in the local languages, an agreed translation 
of the various questions, concepts and common terminology in the local languages was arrived at to ensure 
uniformity. In order to ensure that questions in the structured questionnaire are meaningful and easily understand 
by respondents, pre-testing was conducted at the Haematology department of the Korle-Bu Teaching Hospital 
and necessary amendments were made to improve the reliability and validity of the questionnaire. Filled 
questionnaires was numbered and checked for completeness, clarity and consistency at the end of each interview 
before storage. After data entry, backups were made on external hard drives and compact discs (CD). 
2.7 Ethical consideration and Quality Control 
An Institutional Review Board (IRB), the Committee for Human Research, Publications and Ethics (CHRPE) of 
the KNUST/ KATH, provided ethical clearance for the study.  Permission was also sought from the relevant 
authorities at the hospital in which the study was carried out. Verbal and written informed consent for the study 
was obtained from the patients. The consent form was translated into the local language for those who could not 
read in English. The potential risks and benefits of the survey were explained to the participants and they were 
given the option to leave anytime they did not feel like being part of the study.  
2.8 Data analysis  
Data were analysed using Statistical Package for Social Scientist (SPSS) version 16.0. Descriptive statistics were 
used to summarise data into frequencies tables, figures, cross tabulations, and percentages. Non-parametric tests 
(Pearson's chi-square) were performed to enable inferences to be drawn and to test the significance of some of 
the variables.   
3. RESULTS AND DISCUSSION 
3.1 Background/Clinical characteristics 
Table 1 shows the background/clinical characteristics of the respondents. Participants were mostly women, 
making an 83% of the total population. The age ranged from 25 to 85 years with 43% falling in the middle age 
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class (46-65). More than half of the participants were married, 11% were divorced, 18% were single and 9% 
were widowed. About 66% of the participants had had some sort of education up to the secondary level while 
29% had tertiary education and so the researcher was very convinced that they truly understood the processes 
that the treatment was taking them through and could easily express their feelings.  63% of the participants were 
employed while 20% and 17% were unemployed and retired respectively. Some 57% of the participants earned 
below GH C 500 with just 19% earning above GHC 1000. Most of the participants were in the third stage of the 
disease (52%), 24% and 23% were in the second and forth stages respectively with just 1% of the population in 
the first stage of the disease. 75% of the participants were in the curative stage of the disease while 25% were in 
the palliative stage. 63% of the participants had breast cancer; cervix, ovary, prostrate and H&N (Head and 
Neck) cancers accounted for the remaining 37%, implying that cancers of the breast are more prevalent. 
3.2 Total HADS scores 
Table 2 shows the total HADS scores (distress) with anxiety and depression sub scores of participants. 
According to the scale, over half of the study participants (59%) were distressed. 38% of the participants had no 
anxiety, 25% of the participants were on the borderline and 37% had anxiety. With the depression, 24% of the 
participants were depressed and 29% were on the borderline of being depressed. Fig. 1 also shows a pictorial 
view of the total HADS scores. There have been a lot of studies on emotional distress and cancer. Some 
comparisons can be made with some studies. In almost all the studies conducted in various regions and hospitals, 
no matter the instrument used, found patients to be suffering from distress. Zainal et al (2007) in a study used the 
HADS and found out that the comparing prevalence rates for distress was 51% and 32% were either anxious or 
depressed. Zabora et al, (2001) in a study from the USA using the Brief Symptom Inventory, found the 
prevalence of distress as 35%, 24% for anxiety and 19%  for depression. A survey done at four Sydney Hospitals 
in Australia on oncology patients using the HADS, found out that 31% were distress, 12% had anxiety and 7% 
had depression (Pascoe et al, 2000).Carlson et al, 2004 in their study using a Brief Symptom Inventory-18 (BSI-
18) and a common problems checklist found out that almost 40% of the patients were distressed, with 36% and 
30% having depression and anxiety respectively. In South Africa, Berard et al, (1998) in their research using the 
depression scale in HADS found out that the prevalence of depression was 14%.  
Norton et al (2004) looking at ovarian cancers undergoing chemotherapy, came out that approximately one –fifth 
of the patients were moderately or severely distressed. Strong et al (2007) in a study in Edinburgh, UK using 
HADS found out that the prevalence of distress was 22% and also Senf et al (2010) in their study of acute cancer 
patients found that 56.3% were distressed. 
Persons with cancer will find that their feelings of distress increase or decrease at different times. A patient may 
become more anxious or depressed as cancer spreads or treatment becomes more intense. The level of anxiety or 
depression experienced by one person with cancer may differ from that experienced by another person. Most 
patients are able to reduce their distress by learning more about their cancer and the treatment they can expect to 
receive. For some patients, particularly those who have experienced episodes of intense distress before their 
cancer diagnosis, feelings of anxiety/depression may become overwhelming and interfere with cancer treatment 
(NCI, 2009). Investigators have found that 44% of patients with cancer reported some anxiety; 23% reported 
significant anxiety (Stark et al, 2002 and Schag et al, 1989). The rate of depression in cancer patients is higher 
than in the general population and at least as high as the rate associated with other serious medical illnesses 
(Massie, 2004). Newell et al (1999) in a study  of cancer patients, used the HADS  which  showed that 25% of 
participants had clinical levels of anxiety and depression. Bottomley et al (1997) in their systematic review 
concluded that depression was common with a cancer diagnosis. 
At the Korle bu Teaching hospital and in our community, there are no or little support groups and patients 
disintegrate slowly as a result of the stigma attached to cancer leading to an increase patient’s distress level. 
Holland (2002) noted that no disease has sustained as strong negative stigma as cancer and that cancer diagnosis 
leads to a complex set of issues including dealing with physical symptoms from disease and treatments. 
Quite a number of cancer patients suffer distress, which builds into mental disorders and psychosocial crises. 
Zabora et al, (2001), found out in their study that early detection and subsequently intervention was very 
important when cancer is concerned to avoid psychosocial crises like this study suggests. According to Keller et 
al, (2004) there is  a remarkable proportion of distressed patients who remained unrecognized by the medical 
staff, only systematic screening of patients upon admission allows timely support to those who are most in need. 
Pascoe et al, (2000) suggested in their study the importance of support services for distressed cancer patients. 
However, a majority of affected patients were not accessing counselling or psychological treatment in areas that 
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offered them. However, in Ghana, these services are rare. A systematic screening of oncology patients at hospital 
entry might enable more immediate identification of clinically affected patients, who could then be referred for 
further testing or psychological treatment. 
3.3 Side Effects of Chemotherapy and Emotional Distress 
Side effects emerge as a result of the treatment (chemotherapy) that participants go through. There are quite a 
number of them. Table 6, 7 and 8 shows most of the side effects that participants go through. The table indicates 
that most of the participants did not experience the minor side effects that came with the treatment. Those who 
experienced any of the minor side effects were negligible. For instance only 4% had swollen legs with fluid and 
pain in the joints while 9% had pounding headaches that lasted 15 hours and hot flushes during the day. Looking 
at table 4.3.1, it shows the ten most common side effects experienced by the participants. Hair loss seem to be 
the most experienced physical effect of chemotherapy. 71% of participant loss their hair, 62% s had their skin 
colour changed, 60 % had constipation and 59% had nausea as a result of treatment. Fig. 2 also shows 
prevalence of the common side effects. Chemotherapy is considered a systemic treatment and due to this it 
results in a lot of side effects, which may be temporary and uncomfortable including nausea and vomiting, 
alopecia, diarrhoea, anorexia, stomatitis fatigue, immunosuppression and others which usually may resolve once 
treatment is complete.  These side effects bring about a lot of psychological effects such as anxiety and 
depression. Pandey et al (2006) emphasized that chemotherapy is an intense and cyclic treatment and unlike 
surgery has many side-effects like hair loss, nausea, vomiting, and diarrhoea. Long periods of treatment, 
repeated hospitalizations and side-effects of chemotherapy beside the knowledge of having cancer can all affect 
the psyche of these patients. 
 
In our study, the top ten side effects were considered with the level of distress among patients.  It was noted that 
hair loss, change in skin colour, nausea, ,vomiting, lack of skin colour, night sweats/hot flushes, aches  in jaw 
and diarrhoea were the ten most common experienced side effects. Most of them contributed significantly to 
high distress levels. Similarly there had been a lot of existing research that emphasizes the effect of 
chemotherapy physical effects on patients’ distress level. Love et al (2006) in their study found out that nausea, 
hair loss, and tiredness were each experienced by more than 80% of patients. They also found out that the side 
effects of chemotherapy were a good predictor of emotional distress. Brinkley (1983) in a systematic review 
found out that those physical effects of the treatment: nausea, vomiting, diarrhoea, general debility, and alopecia; 
loss of taste, appetite, and sexual function all contribute to feelings of helplessness and lack of control. Another 
study found that the number of side effects experienced is positively correlated to emotional distress and that 
those who experienced nausea during treatment was reported to have higher distress levels. (Nerenz et al, 1982)  
 
The results from this study revealed that cancer patients undergoing chemotherapy do experience distress and it 
showed that there is a relationship between emotional distress and side effects of chemotherapy. 
 
3.4. Factors affecting emotional Distress 
3.4.1 Background /clinical characteristics compared with HAD Scores 
Table 7 and 8 show the relationship between demographic variables and the anxiety sub score. Sex of 
participants was used to determine if a particular sex experienced more anxiety than the other. In each of the 
categories, there were more females than males. The age of participants showed that persons in the 25-45 age 
bracket were more anxious than any of the other age groups though those in the 46-65 age group followed 
without any great differences. The table shows that those aged between 66 and 85 were less anxious in all the 
categories. Those that were married experienced anxiety than any of the other groups – single, divorced, 
separated and widow/widower. However, married people once again made a chunk of the borderline and 
abnormal group in anxiety sub scale. Looking at the marital status, the differences statistically was of a 
borderline significance.  Participants who were employed were highly anxious. Besides the fact that 33% of 
participants were in the normal line, 38.5% persons were on the abnormal line, while 28.6% were on the 
borderline. Compared with those who are unemployed or retired, 46.4% persons were both on the normal and 
abnormal line while just 32% of people were anxious. 
The income levels of participants significantly contributed to anxiety of participants (p-value=0.021). Those that 
earned less than 500 cedis tended to experience more anxiety that those that earned more than 500 cedis. Only a 
small number of those who earned more than GH1000 had experienced anxiety. 
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3.4.2 Depression  
The low level of education (p-value=0.005) and low income levels (p-value=0.004) were significantly related to 
depression of participants. Married people were more depressed than those who were not married or widowed, 
with 26.7% and 27.7% being on the borderline and depression respectively. Those that were employed were 
highly depressed than those who were not, however the highest number (47.3%) of those that were normal were 
also in the employed group. With income levels those who were receiving an income below GH C500 were more 
depressed. With the educational status, those who had up to primary/elementary education were more depressed 
than those in the secondary and tertiary category. Table 9 shows the relationship between demographic variables 
and depression sub score. 
3.4.3 Emotional distress status 
Table 4.4.2 and Fig. 4.3.I & II shows the relationship between distress and demographic characteristics. A total 
score of both anxiety and depression sub scores were also looked at. A mark less than 15 indicated that the 
participant was not distressed and a mark greater than 15 showed that the participant was distressed. Those in the 
age 25-45 group were more distressed than the other age groups (p-value=0.05). In the employment category, 
those who were employed were more distressed than those who were not employed (p-value<0.026). Participants 
who earned less than GH500 were also seen to be more distressed than those who earn more than GH500 (p-
value=0.003).With the educational category, those who never had education (71%) and those with primary 
/elementary education (79.2%) were more distressed (p-value=0.005) than those in the other groups. This means 
that those who were more distressed lack or had little information about their disease and its treatments. To 
further investigate the distress level of participants, their place of residence was assessed and it was realised that 
urban dwellers were more distressed than rural residents.  
Table 4.4.3 shows the relationship between clinical variables and distress. Breast cancer patients were more 
distressed than any of the participants with other forms of cancers. Though other cancers had some level of 
distressed out of the 94 participants who had breast cancer, 57 (60.6%) were distressed. cervical, ovary and head 
& neck cancer patients also showed some level of distress. Those participants who were in the curative phase of 
the treatment were more distressed than those in the palliative stage. Those having stage three diseases were 
more distressed than those in the other stages. Also those having cycle 5 and above were more distressed. The 
clinical variables did not significantly contribute to distress of participants 
 
Table 4.4.4 showing the relationship between side effect of chemotherapy and distress level. Participants 
experienced a lot of side effects from the chemotherapy. The ten most common side effects were assessed in 
relation to distress. It was noted that some of the participants who had these physical effects had some form of 
distress. Hair loss being the highest; out of 101 participants who had hair loss, 67% of them were distressed. Chi-
square analysis showed that hair loss (p-value=0.001), nausea (p-value=0.051), lack of sleep (p- value=0.013), 
night sweats (p-value=0.005), hot flushes and change sleep patterns and diarrhoea (p-value= 0.031) significantly 
related to distress levels of participants. Aching jaw was at a borderline significance. Also a chart (fig.4.4) shows 
a pictorial presentation of the relationship between the side effects of chemotherapy and distress status of 
participants. 
There are several factors that affect emotional distress among cancer patients. The disease condition on one hand 
and the treatment regimen on the other hand.  Strong et al (2007 in their research, found out that there were an 
association with age < 65, female gender, cancer type and extent of disease. Zabora et al (2001) also found 
younger age and lower income to be associated with higher levels of distress. Also Pascoe et al (2000) found that 
gender, aged <65 years and having advanced disease were associated with distress, but they all did not find an 
association with employment status and level of education. Also, Senf et al (2010) in their study of acute cancer 
patients found out that the younger age, those with metastasis and poor functional status were distressed.   
In our study it was seen that younger age (p=0.052), employment status (p=0.026), income level (p=0.003) and 
educational level (p=0.005) were all significantly related to the distress status of the participants but there was no 
relationship with gender, cancer type and stage of disease. With age those below age 45 were seen to be more 
distressed. Those at this age may have a lot of ambitions and responsibilities. The fear of the unknown plays a 
big part in their lives. Those who were employed were more distressed. This could be due to the fact that they 
had to combine their work with the scheduled treatments or whether they could still have their job back if people 
know about their disease. This may put a lot of stress on the cancer patients. Cancer drugs are very expensive; 
low income levels means inability to afford which may also increase the distress levels of participants. The 
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complex nature of cancer and it management is not easy to understand and assimilate. This could mean that those 
with no or little education may have some difficulties which may increase their distress levels. 
Bottomley et al (1997) established through a literature search that women were at greater risk of developing 
depression, which has also been evidenced in this current research. In our study we also found that more women 
(86.5%) were distressed (i.e. anxiety or depression) than men (13.5%). Friedman et al (1994) study of the 
relationship between anxiety and the socio-demographic variables in adult cancer patients indicates that females 
and patients who reported more communication problems with friends or relatives reported more anxiety and had 
more chemotherapy-related problems. Comparison of specific areas of adjustment suggests that women 
experience more difficulties in relation to body image and concerns of an emotional nature, while men are more 
likely to report practical difficulties with physical symptoms or impairment of functioning (Liang et al, 1990; 
Noyes et al, 1990). 
6.0 CONCLUSION 
Emotional distress is relatively high in cancer patients receiving chemotherapy and it is affected by a group of 
factors, patient’s demographic and clinical characteristics. Of all these early identification and treatment of 
psychological problems has the probability to affect psychological and physical health outcomes. Early 
identification and intervention will be easier if health professionals predict a more vulnerable point during the 
treatment for their patient to develop distress and act accordingly using a multi-disciplinary approach. Good 
psychological support and the management of chemotherapy side effects, patients assessment  and  good rapport  
between patients and practitioner is  necessary to enhancing continuity and quality of care delivered to cancer 
patients. This study showed that experience of emotional distress has negative impact on patient treatment and 
quality of life. They also have poorer treatment compliance and place a greater strain on the health care system. 
Results indicated that most of the cancer patients were distressed. This study, using HADS, identifies the distress 
levels of cancer patients undergoing chemotherapy is relatively high as 59% of the total participants were 
distressed. The study found out that the younger age, employment status, low income levels and low level of 
education significantly related to the distress level of patients. The study also found out that side effects from 
chemotherapy experienced by patients also contributed to the distress level of the participants. 
With respect to the advancement in cancer care, little is done in relation to psychological morbidities. The study 
emphasized the prevalence of emotional distress in cancer patients undergoing chemotherapy and the need to 
provide services which will take care of this.  
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TABLES 
Table 1: Background (Demographic/clinical) characteristics 
Demographic/clinical Variables Frequency, N=150 Percentages 
Sex   
   Male 25 17 
   Female  125 83 
Age   
   25-45 68 45 
   46-65 64 43 
   66-85 18 12 
Marital status   
   Single 18 12 
   Married 101 68 
   Divorced 16 11 
   Separated 5 3 
   Widow/widower 9 6 
Educational level   
   None 7 5 
   Primary/elementary 48 33 
   Secondary 49 33 
   Tertiary 43 29 
Employment status   
   Employed 91 63 
   Unemployed 28 20 
   Retired 25 17 
Expected income   
   Below 500 71 57 
   501-1000 30 24 
   Above 1000 23 19 
Residence of patients   
   Urban 100 83 
   Rural 21 17 
Stage of disease   
   Stage 1 2 1 
   Stage 2 35 24 
   Stage 3 78 52 
   Stage 4 34 23 
Phase of treatment   
   Curative 110 75 
   Palliative 37 25 
   Tumour site   
   Breast 94 63 
   Cervix 10 7 
   Prostrate 3 2 
   Ovary 13 9 
   H&N 11 7 
Others 18 12 
Phase of chemotherapy   
   Cycle 1-2 22 17 
   Cycle 3-4 29 23 
   Cycle 5 and above 77 60 
Total 150 100 
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Table 2: The HADS scores 
Variable Scale Cut-off Criteria Frequency Percentage 
Total HADS Normal <15 61 41% Abnormal (Distress) ≥ 15 89 59% 
Anxiety Sub-Scale 
Normal 0-7 58 38% 
Borderline 8 - 10 37 25% 
Abnormal(Anxiety) 11 -21 55 37% 
Depression Sub-
Scale 
Normal 0-7 71 47% 
Borderline 8 – 10 43 29% 
Abnormal (Depression) 11 - 21 36 24% 
 
Table 3: Ten most common side effects of chemotherapy 
Side Effects Frequency, N=150 Percentage (%) 
Hair loss   
No 44 29 
Yes 106 71 
Change of skin colour 
No 57 38 
Yes 93 62 
Constipation   
No 60 40 
Yes 90 60 
Nausea   
No 62 41 
Yes 88 59 
Lack of sleep   
No 85 57 
Yes 65 43 
Dizziness(gradually wears off after a week or so) 
No 90 60 
Yes  60 40 
Vomiting   
No 94 63 
Yes 56 37 
Night sweats, hot flushes and change sleep patterns 
No 101 67 
Yes 49 33 
Aching jaw   
No 101 68 
Yes 48 32 
Diarrhoea   
No 106 71 
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0-7 8-10 11-21 P-Value 
Normal Borderline Abnormal  
Sex      
Male 13 (52%) 7 (28%) 5 (20%) 3.787 0.151 Female 45 (36%) 30 (24%) 50 (40%) 
Age 
     
25-45 23 (33.8%) 17 (25%) 28 (41.2%) 
  
46-65 22 (34.4%) 18 (28.1%) 24 (37.5%) 9.966 0.41 
66-85 13 (72.2%) 2 (11.1%) 3 (16.7%) 
  
Marital status      
Single 7 (38.9%) 3 (16.7%) 8 (44.4%)   
Married 36 (38.9%) 24 (23.8%) 41 (40.6%) 
14 
 
Divorced 6 (35.6%) 7 (43.8%) 3 (18.8%) 0.082 Separated 5 (100.0%) 0 (0%) 0 (0%) 
Window 4 (44.4%) 3 (33.3%) 2 (22.2%)  
Employment status       
Employed 30 (33.0%) 26 (28.6%) 35 (38.5%)   
Unemployed 13 (46.4%) 6 (21.4%) 9 (32.1%) 4.907 0.297 
Retired 13 (52.0%) 3 (12.0%) 9 (36.0%)   
Expected income per month (GHC) 
     
500 and below 19 (26.8) 20 (28.2%) 32 (45.1%)   
501-1000 12 (40.0%) 6 (20.0%) 12 (40.0%) 11.593 0.021 
Above 1000 15 (65.2%) 4 (17.4%) 4 (17.4%)   
Level of education 
     
None 2 (28.6%) 3 (42.9%) 2 (28.6%) 
  
Primary/elementary 14 (29.2%) 13 (27.1%) 21 (43.8%) 5.027 0.540 
Secondary 21 (42.9%) 9 (18.4%) 19 (38.8%) 
  
Tertiary 19 (44.2%) 11 (25.6%) 13 (30.2%) 
  
 





0-7 8-10 11-21 P-Value 
Normal Borderline Abnormal  
Sex      
Male 14 (55.0%) 9 (36.0%) 2 (8.0%) 4.239 0.120 Female 57 (45.6%) 34 (27.2%) 34 (27.2%) 
Age 
     
25-45 27 (39.7%) 20 (29.4%) 21 (30.9%) 
  
46-65 33 (51.6%) 18 (28.1%) 13 (20.3%) 4.775 0.311 
66-85 11 (61.1%) 5 (27.8%) 2 (11.1%) 
  
Marital status      
Single 10 (55.6%) 7 (38.9%) 1 (5.6%)   
Married 46 (45.5%) 27 (26.7%) 28 (27.7%) 
8.875 0.353 Divorced 6 (37.5%) 4 (25.0%) 6 (36.5%) Separated 3 (60.0%) 2 (40.0%) 0 (0.0%) 
Window 6 (66.7%) 2 (22.2%) 1 (11.1%) 
Employment status       
Employed 43 (47.3%) 27 (29.7%) 21 (23.1%)   
Unemployed 15 (53.6%) 6 (21.4%) 7 (25.0%) 0.954 0.917 
Retired 11 (44.0%) 8 (32.0%) 6 (24.0%)   
Expected income per month (GHC) 
     
500 and below 27 (39.0%) 22 (31.0%) 22 (31.0%)   
501-1000 13 (43.3%) 11 (36.7%) 6 (20.0%) 15.592 0.004 
Above 1000 19 (82.6%) 3 (13.0%) 1 (4.3%)   
Level of education 
     
None 3 (42.9%) 3 (42.9%) 1 (14.3%) 
  
Primary/elementary 14 (29.2%) 18 (37.5%) 16 (33.3%) 18.623 0.005 
Secondary 20 (40.8%) 16 (32.7%) 13 (26.5%) 
  
Tertiary 31 (72.1%) 6 (14.0%) 6 (14.0%) 
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Table 6: Relationship between Demographic Characteristics and Distress Status  
Variable Distress Status X2 P-VALUE 
<15 normal >15 distress 
Sex     
Male 13 (52.0%) 12 (48%) 1.597 0.206 
Female 48 (38.4%) 77 (61.6%)   
Age     
25-45 24 (35.3%) 44 (64.7%)   
46-65 25 (39.1%) 39 (60.9%) 5.925 0.052 
66-85 12 (66.7%) 6 (33.3%)   
Marital status     
Single 7 (38.9%) 11 (61.1%)   
Married 39 (39.6%) 62 (61.4%)   
Divorced 8 (50.0%) 8 (50.0%) 1.597 0.809 
Separated 3 (60.0%) 2 (40.0%)   
Window 4 (44.4%) 5 (55.6%)   
Employment status      
Employed 29 (31.9%) 62 (68.1%)   
Unemployed 15 (53.6%) 13 (46.4%) 7.302 0.026 
Retired 14 (56.0%) 11 (44.0%)  
 
Expected income per 
month (GHC) 
    
500 and below 21 (29.6%) 50 (70.4%)   
501-1000 12 (40.0%) 18 (60.0%) 11.262 0.003 
Above 1000 16 (69.6%) 7 (30.4%)   
Level of education     
None 2 (28.6%) 5 (71.4%)   
Primary/elementary 10 (20.8%) 38 (79.2%) 12.740 0.005 
Secondary 22 (44.9%) 27 (55.1%)   
Tertiary 24 (55.8%) 19 (44.2%)   
Residence of patient     
Rural 5 (23.8%) 16 (76.2%) 2.177 0.140 
Urban 41 (41.0%) 59 (59.0%)   
 
Table 7: Relationship between Chemotherapy Side Effects and Distress Status 
Ten most common side effects 
Distress Status 
X2 P-VALUE 
<15 normal >15 distress 
Hair loss 34 (32.1%) 72 (67.9%) 11.054 0.001 
Change in skin colour 34 (36.6%) 59 (63.4%) 1.711 0.191 
Nausea 30 (34.1%) 58 (65.9%) 3.815 0.051 
Constipation 32 (35.6%) 58 (64.4%) 2.436 0.119 
Dizziness(gradually wears off after a week or 
so) 
21 (35.0%) 39 (65.0%) 1.331 0.249 
Vomiting 18 (32.1%) 38 (67.9%) 2.691 0.101 
Lack of sleep 19 (29.2%) 46 (70.8%) 6.217 0.013 
Night sweats, hot flushes and change sleep 
patterns 
12 (24.5%) 37 (75.5%) 7.893 0.005 
Aching jaw 14 (29.2%) 34 (70.8%) 3.628 0.057 
Diarrhoea 12 (27.3%) 32 (72.7%) 4.629 0.031 
 
 
